RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Esmolol 2500 mg/10ml ampoule
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Peripheral Vascular Disease Therapy Area Pipeline Report
Nov 2010 - 123 pages - $1,495
Abbott Laboratories: PharmaVitae Report
May 2011 - 95 pages - $5,700
Vascular Dysfunction - Pipeline Review, Q3 2011
Jul 2011 - 29 pages - $500
Nicotine Dependence Market Forecast
Mar 2009 - $15,200
Vascular Injury - Pipeline Review, Q2 2011
May 2011 - 30 pages - $500
Eli Lilly & Co.: PharmaVitae Report
Jun 2011 - 92 pages - $5,700
Eli Lilly & Co.: PharmaVitae Profile
Jul 2010 - 101 pages - $5,700
Apotex Inc.: PharmaVitae Profile
Dec 2010 - 37 pages - $5,700
Vascular Dysfunction - Pipeline Review, Q1 2011
Jan 2011 - 19 pages - $500
Teva Pharmaceutical Industries Ltd: PharmaVitae Profile
Mar 2009 - 59 pages - $5,700
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Prescription del
Therapeutic target
Cardiovascular del
Vascular del
Development phase
Early Stage del

Browse By

Therapeutic target
Angiogenesis
Atherosclerosis
Hypertension
Hypotension
Ischemia

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us